CEREPRO

DEAD

Serial Number

78258657

Owner

Ark Therapeutics Limited

Attorney

Ronald E. Shapiro

Filing Date

Jun 5, 2003

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

CEREPRO Trademark

Serial Number: 78258657 • Registration: 3301634

CEREPRO is a trademark filed by Ark Therapeutics Limited on June 5, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Ark Therapeutics Limited (15 trademarks)

79 New Cavendish Street
London W1W 6XB , GB

Entity Type: 03

FINVECTOR VISION THERAPIES LTD

OAKLEY ROAD
CHINNOR, OXFORDSHIRE OX39 4TW , GB

Entity Type: 99

Legal Representation

Attorney of Record

Ronald E. Shapiro

4,541 trademarks filed View all →

Trademark Details

Filing Date

June 5, 2003

Registration Date

October 2, 2007

Published for Opposition

July 17, 2007

Cancellation Date

May 4, 2018

Goods & Services

PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS FOR THE TREATMENT OF MALIGNANT GLIOMA AND OTHER MALIGNANT BRAIN TUMORS; PHARMACEUTICAL PREPARATIONS IN THE NATURE OF VIRAL VECTORS FOR THE TREATMENT OF CANCER, CANCER VACCINES; PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY(Based on 44(d) Priority Application) PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS FOR THE TREATMENT OF MALIGNANT GLIOMA AND OTHER MALIGNANT BRAIN TUMORS; PHARMACEUTICAL PREPARATIONS IN THE NATURE OF VIRAL VECTORS FOR THE TREATMENT OF CANCER, CANCER VACCINES; PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

May 4, 2018 CAEX

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Oct 2, 2016 REM2

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Sep 18, 2013 ASGN

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Sep 18, 2013 NAS8

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Sep 18, 2013 8.OK

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Sep 18, 2013 APRE

REGISTERED - SEC. 8 (6-YR) FILED

Sep 17, 2013 8.AF

TEAS SECTION 8 RECEIVED

Sep 17, 2013 ES8R

REGISTERED-PRINCIPAL REGISTER

Oct 2, 2007 R.PR

PUBLISHED FOR OPPOSITION

Jul 17, 2007 PUBO

NOTICE OF PUBLICATION

Jun 27, 2007 NPUB

LAW OFFICE PUBLICATION REVIEW COMPLETED

Jun 12, 2007 PREV

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 12, 2007 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

May 29, 2007 TEME

ASSIGNED TO LIE

May 26, 2007 ALIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 10, 2007 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 10, 2007 TROA

INQUIRY TO SUSPENSION E-MAILED

Nov 17, 2006 GNSI

SUSPENSION INQUIRY WRITTEN

Nov 17, 2006 CNSI

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Oct 30, 2006 RCCK

LETTER OF SUSPENSION E-MAILED

Mar 31, 2006 GNSL

SUSPENSION LETTER WRITTEN

Mar 31, 2006 CNSL

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Sep 28, 2005 COAR

DATA MODIFICATION COMPLETED

Sep 16, 2005 DMCC

PAPER RECEIVED

Sep 8, 2005 MAIL

INQUIRY TO SUSPENSION E-MAILED

Apr 26, 2005 GNSI

SUSPENSION INQUIRY WRITTEN

Apr 26, 2005 CNSI

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Mar 31, 2005 RCCK

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Sep 18, 2004 RCSC

LETTER OF SUSPENSION E-MAILED

Mar 29, 2004 GNSL

EMAIL RECEIVED

Jan 30, 2004 EMRV

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 29, 2004 CRFA

NON-FINAL ACTION E-MAILED

Oct 27, 2003 GNRT

ASSIGNED TO EXAMINER

Oct 19, 2003 DOCK

Related Trademarks

More from this Owner

ARK THERAPEUTICS

More in Same Class

WHEN PRESSED FOR TIME, ONLY HEMOSTASIS MATTERS

APOPTINE

HIMALAYAN GOJI

IF THE PROCEDURE IS MINIMALLY INVASIVE, BLEEDING CONTROL MUST BE NON-INVASIVE

FLEET-LYTE

PC-NSAID